BACKGROUND:
The Perinatal Hepatitis B (PHB) program is responsible for investigating reported cases of pregnant women diagnosed with Hepatitis B. The responsibility extends to ensuring that the baby is administered HBIG, the complete hepatitis B vaccine series (including birth dose), and tested for serologic immunity. The program works with hospitals to provide the birth dose of Hepatitis B to all infants.

OBJECTIVE:
1. To determine if HBsAg screening was performed and factors related to why the screening had not occurred or was not reported.
2. To determine if the birth dose of Hepatitis B is provided universally and factors related to why the birth dose was not administered.
3. To determine PHB program effectiveness and areas needing improvement

METHOD:
A statistically significant number of hospital maternal and infant records from the first 6 months of 2004 were randomly selected and assessed. No individual identifying information was collected. A standardized survey form was used collecting data on the following indicators:
•Ethnicity of mother/child
•Type of Healthcare Insurance Coverage
•Confirmation of the date prenatal care began
•Evidence of Rubella testing (comparison with Hepatitis B testing)
•Evidence of HBsAg testing performed during this pregnancy
•Presence of actual laboratory report for HBsAg as opposed to transcribed results
•Administration of the birth dose of Hepatitis B to newborn
•Administration of HBIG and Hepatitis B birth dose within 12 hours if mother HBsAg positive
•Whether PHB Field Investigator was notified of delivery of an infant to HBsAg positive mother


RESULT:
In process. The presentation will detail the results of the records review. Areas for program improvement will be targeted and successes highlighted.

CONCLUSION:
To be determined. This is a pilot study. After the study is completed, the record review will be replicated in other Indiana hospitals.

LEARNING OBJECTIVES:
1.Establish working relationship with hospitals to review PHB records.
2.Describe factors associated with or limiting Hepatitis B screening.
3.Describe factors associated with universal Hepatitis B birth dose administration.
4.Identify key areas of success and improvements needed in the PHB program.